Insider Transactions in Q3 2024 at New Amsterdam Pharma CO N.V. (NAMS)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 27
2024
|
Louise Frederika Kooij Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
45,000
+50.0%
|
-
|
|
Sep 26
2024
|
Juliette Berangere Audet Chief Business Officer |
BUY
Open market or private purchase
|
Direct |
1,104
+50.0%
|
$16,560
$15.7 P/Share
|
|
Aug 20
2024
|
Michael H. Davidson Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+2.33%
|
$80,000
$16.27 P/Share
|